In this article, we will take a look at the 15 Blue Chip Stocks with Highest Dividends.
Blue-chip stocks refer to shares of large, well-established companies that lead their industries. These businesses are typically financially strong, which makes them less risky compared to others. Because of that stability, their dividend policies tend to be more consistent.
Over time, dividends have played a meaningful role in overall returns. A report by Eagle Global Advisors highlighted how that role has shifted. It noted that the contribution of dividends to total equity returns depends on interest rates and the broader economic outlook. In the high-rate, high-inflation environment of the 1970s, dividends made up 73% of the S&P 500 total return. In contrast, during the low-rate, high-growth period of the 2010s, that share dropped to 17%.
Looking at the full period from 1940 to 2019, dividends accounted for 42% of total returns. That figure stands out and may come as a surprise to some. Beyond total return, growing dividends have offered other benefits. They have provided income for retirement, helped offset inflation, reduced portfolio volatility, and lowered the need to rely on market timing.
The report also cited research from Ned Davis Research, which groups stocks into Dividend Growers, Payers, No Change, Non-Payers, and Cutters. Since 1972, Dividend Growers and Initiators have outperformed all other categories. On the other end, Dividend Cutters and Eliminators have delivered the weakest results. The gap in total returns between these groups has been meaningful.
Given this, we will take a look at some of the best blue-chip stocks with the highest dividends.
Image by Alexsander-777 from Pixabay
Our Methodology:
For this list, we screened for dividend companies with market caps above $10 billion. From that group, we identified dividend stocks that have yields above 4%, as of April 8. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
15. AT&T Inc. (NYSE:T)
Dividend Yield as of April 8: 4.06%
On April 8, BNP Paribas analyst Sam McHugh downgraded AT&T Inc. (NYSE:T) to Neutral from Outperform. The firm set a $28 price target on the shares.
On April 1, Scotiabank analyst Maher Yaghi raised the firm’s price target on AT&T to $31.50 from $31 and kept a Sector Perform rating on the shares. The firm said the U.S. wireless pricing environment remains “competitive yet rational” and is conducive to growth, the analyst told investors. Scotiabank lifted its target ahead of Q1 results, pointing to improved profitability expectations.
A March 31 report by the Wall Street Journal said AT&T reached a revised agreement worth up to $2 billion to enhance the FirstNet emergency communications network it operates for the US government. In exchange for committing to additional system upgrades and lower service rates, the company will receive faster regulatory approvals.
The updated terms came after months of discussions between CEO John Stankey and Commerce Secretary Howard Lutnick. Those talks followed a 2025 directive that asked federal agencies to review existing contracts.FirstNet was launched in 2017 with $6.5 billion in public funding. It operates as a public-private partnership and provides priority network access to around 31,000 public safety agencies. AT&T is responsible for maintaining nationwide coverage, including in areas that are not commercially viable.
Under the new agreement, AT&T plans to invest more in network upgrades and reduce certain service fees. These changes could save the government up to $1 billion. In return, the Commerce Department will speed up approval processes. Some provisions of the deal will run through 2033, in line with expected 5G upgrades. The broader contract remains in place until 2042. The agreement comes as FirstNet faces renewed scrutiny ahead of its upcoming reauthorization vote.
AT&T Inc. (NYSE:T) operates as a holding company and provides telecommunications and technology services globally. Its business is divided into Communications and Latin America segments. The Communications unit offers wireless, wireline telecom, and broadband services to U.S. consumers and businesses worldwide.
14. Bristol-Myers Squibb Company (NYSE:BMY)
Dividend Yield as of April 8: 4.26%
On April 8, Cantor Fitzgerald raised the firm’s price recommendation on Bristol-Myers Squibb Company (NYSE:BMY) to $54 from $45. It reiterated a Neutral rating on the shares. The firm said it does not expect the Q1 earnings season to “dramatically reinvigorate” the large-cap pharma sector. Cantor pointed instead to the second half of 2026, noting that catalysts tied to admilparant, milvexian and Cobenfy carry more weight than a “primarily legacy-driven beat” in Q1.
On March 31, Bristol Myers Squibb reported positive results from a late-stage study of its drug Camzyos in teenagers with obstructive hypertrophic cardiomyopathy. The study showed that Camzyos reduced pressure in the heart more than a placebo after 28 weeks. The improvement was both clinically meaningful and statistically significant.
The drug also showed benefits across several secondary measures, pointing to broader impact. Safety outcomes remained consistent between patients receiving Camzyos and those given a placebo. The results were presented at the American College of Cardiology Annual Scientific Session & Expo 2026 and published in The New England Journal of Medicine.
Bristol-Myers Squibb Company (NYSE:BMY) operates as a global biopharmaceutical company. It focuses on discovering, developing, and delivering medicines for serious diseases, including oncology, hematology, immunology, cardiovascular, and neuroscience.
